Références
ADLER R.H., RODRIGUEZ J. (1959). The association of hiatus hernia and gastrœsophageal malignancy.J. Thorac. Surg., 37, 553–569.
ARMSTRONG R.A., BLALOCK J.B., CARRERA G.M. (1959). Adenocarcinoma of the middle third of the esophagus arising from ectopic gastric mucosa.J. Thorac. Surg., 37.
BARRETT N.R. (1950). Chronic peptic ulcer of the esophagus and esophagitis.Br. J. Surg., 175–182.
BARRETT N.R. (1957). The lower esophagus lined by columnar epithelium.Surgery, 41.
BORRIE J., GOLDWATER L. (1976). Columnar cell-lined esophagus: assessment of etiology and treatment. A 22-year experience.J. Thorac. Cardiovasc. Surg., 71, 825–834.
BRAND D.L., YLVISAKER J.T., GELFAND M., POPE C.E. II (1980). Regression of columnar esophageal (Barrett’s) epithelium after antireflux surgery.N. Engl. J. Med., 302.
BREMNER C.G. (1982). Benign strictures of the esophagus.Current problems in Surg., 402–492.
BULKLEY G.B. (1983). The role of oxygen free radicals in human disease processes.Surgery, 94, 403–407.
CAMERON A.J., OTT B.J., PAYNE W.S. (1985). The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus.N. Engl. J. Med., 313: 857–859.
DEBONGNIE J.C, MACCHI H., MAINGUET P. (1981) Schéma planimétrique destiné à la surveillance de l’œsophage à haut risque.Acta Endoscopica, 11,4–5, 353–356.
DEMEESTER T.R., WANG C.I., WERNLY J.A., LITTLE A.G., BERMUDEZ G., SKINNER D.B. (1980) Techniques indications and clinical use of 24-hour esophageal pH-monitoring.J. Thorac. Cardiovasc. Surg., 79,5: 656–667.
DODGE O.G. (1960). Intraœsophageal adenocarcinoma.Gut, 1, 351–356.
GAREWAL H.S., SAMPLINER R.E., FENNERTY M.B. (1991) Flow cytometry in Barrett’s esophagus: What have we learned so far?Dig. Dis. Sci., 36,5, 548–551.
GIULI R. (1988). La dégénérescence de l’œsophagite peptique.IbidDig. Dis. Sci., 36,5, 773–779.
GRIFFIN M., SWEENEY E.C. (1987). The relationship of endocrine cells, dysplasia and carcino-embryonic antigen in Barrett’s mucosa to adenocarcinoma of the esophagus.Histopathology., 11, 53–62.
HAWE A., PAYNE W.S., WEILAND L.H., FONTANA R.S. (1973). Adenocarcinoma in the columnar epithelial lined lower (Barrett’s) esophagus.Thorax, 282, 511–514.
LORTAT-JACOB J.L. (1957). L’endo-brachy-œsophage. Sem. des Hôp.,Annales Chir., 1247–1255.
MESSIAN R.A., HERMOS J.A., ROBBINS A.H., FRIEDLANDER D.M., SCHIMMEL E.M. (1978). Barrett’s esophagus: clinical review of 26 cases.Am. J. Gastroenterol., 69, 458–466.
OLLYO J.B., SAVARY M., MONNIER Ph. WELLINGER J., GONVERS J.J., FONTOLLIET Ch. (1988) La prévalence des adéno-carcinomes chez les sujets porteurs d’un endo-brachy-œsophage n’est-elle pas surestimée ? « Lésions bénignes de l’œsophage et cancer. Réponses à 210 questions ». Giuli R., McCallum R.W. Eds, Springer Verlag, 814–816.
POPE C.E. II (1985). Regression of « Barrett’s epithelium in Barrett’s esophagus: pathophysiology, diagnosis and management ». Spechler and Goyal Eds., Elsevier New York, 223–229.
REID B.J., HAGGITT R.C., RUBIN C.E., RABINOVITCH P.S. (1987) Barrett’s esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.Gastroenterology, 93, 1, 11.
RIBET M., MENSIER E., PRUVOT F.R. (1987). Barrett’s esophagus and adenocarcinoma.Eur. J. Cardio-thorac. Surg., 1, 29–32.
RIDDELL R.H. (1985). Dysplasia and regression of « Barrett’s epithelium in Barrett’s esophagus : pathophysiology, diagnosis and management ». Spechler and Goyal Eds., Elsevier New York, 143–152.
SAMPLINER R., GAREWAL H., KOGAN F., SMITH W., GERNER E., ALBERTS D., KENDALL D. (1986) Elevated ornithine decarboxylase levels in Barrett’s esophagus.Gastroenterology, 90, 5, 1613 (abstract).
SANFEY H., HAMILTON S.R., SMITH R.R.L., CAMERON J.L. (1985) Carcinoma arising in Barrett’s esophagus.Surg. Gynecol. Obstet., 161, 570–574.
SAVARY M., MILLER G. (1977). L’œsophage, Atlas et manuel d’endoscopie. Gassman Ed. Soleure.
SIEWERT J.R. (1988) L’incidence des cancers sur endobrachy-œsophage varie selon les séries. « Lésions bénignes de l’œsophage et cancer. Réponses à 210 questions ». Giuli R., McCallum R.W. Eds, Springer Verlag, 811–813.
SJOGREN R.W., JOHNSON L.F. (1985) Clinical features of Barrett’s esophagus. in: Spechler S.J., Goyal R.K. Eds, Barrett’s esophagus : pathophysiology diagnosis and management. Elsevier, New York, 75–90.
SJOGREN R.W., JOHNSON L.F. (1985). Barrett’s esophagus: a review.Am. J. Med., 74, 313–321.
SKINNER D.B. (1988). Quelle est la définition de l’endobrachy-œsophage? « Lésions bénignes de l’œsophage et cancer. Réponses à 210 questions». Giuli R., McCallum R.W. Eds, Springer Verlag, 658–659.
SKINNER D.B., WALTHER B.C., RIDDELL R.H., SCHMIDT H., IASCONE G., DEMEESTER T.R. 25. Barrett’s esophagus : comparison of benign and malignant cases.Ann. Surg., 554–566.
SPECHLER S.J., SPERBER H., DOOS W.G., SCHIMMEL E.M. (1983). The prevalence of Barrett’s esophagus in patients with chronic peptic esophageal strictures.Dig. Dis. and Sci., 28, 769.
WINTERS C. Jr., SPURLING T.J., CHOBANIAN S.J. et al. (1987). Barrett’s esophagus. A prevalent, occult complication of gastrœsophageal reflux disease.Gastroenterology, 92, 118–124.
Author information
Authors and Affiliations
About this article
Cite this article
Giuli, R. Les problèmes posés par les endo-brachy-œsophages, et l’étude prospective O.E.S.O.. Acta Endosc 23, 63–72 (1993). https://doi.org/10.1007/BF02968616
Issue Date:
DOI: https://doi.org/10.1007/BF02968616